Neuren Pharmaceuticals Limited (ASX: NEU)
Australia
· Delayed Price · Currency is AUD 12.25
-0.25 (-2.00%)
Jan 2, 2025, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.57 billion as of January 2, 2025. Its market cap has decreased by -23.13% in one year.
Market Cap
1.57B
Enterprise Value
1.35B
Revenue
193.34M
Ranking
n/a
PE Ratio
13.70
Stock Price
12.25
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.57B, an increase of 7,380.16%. That is a compound annual growth rate of 24.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 136.34B |
| Pro Medicus | 26.14B |
| Cochlear | 18.97B |
| Sonic Healthcare | 12.97B |
| Telix Pharmaceuticals | 8.24B |
| Ramsay Health Care | 7.92B |
| Ansell | 4.89B |
| Sigma Healthcare | 4.12B |